The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 7 February 2005. doi:10.1084/jem.20041399
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 3, 373-383
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1716K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fugier-Vivier, I. J.
Right arrow Articles by Ildstad, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fugier-Vivier, I. J.
Right arrow Articles by Ildstad, S. T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

 Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment

Isabelle J. Fugier-Vivier1,2, Francine Rezzoug1, Yiming Huang1, Amanda J. Graul-Layman1, Carrie L. Schanie1, Hong Xu1, Paula M. Chilton1, and Suzanne T. Ildstad1

1 Institute for Cellular Therapeutics, University of Louisville, Louisville, KY 40202
2 Department of Physiology and Biophysics, University of Louisville, Louisville, KY 40202

CORRESPONDENCE Suzanne T. Ildstad: suzanne.ildstad{at}louisville.edu

Bone marrow transplantation offers great promise for treating a number of disease states. However, the widespread application of this approach is dependent upon the development of less toxic methods to establish chimerism and avoid graft-versus-host disease (GVHD). CD8+/TCR– facilitating cells (FCs) have been shown to enhance engraftment of hematopoietic stem cells (HSCs) in allogeneic recipients without causing GVHD. In the present studies, we have identified the main subpopulation of FCs as plasmacytoid precursor dendritic cells (p-preDCs). FCs and p-preDCs share many phenotypic, morphological, and functional features: both produce IFN-{alpha} and TNF-{alpha}, both are activated by toll-like receptor (TLR)-9 ligand (CpG ODN) stimulation, and both expand and mature after Flt3 ligand (FL) treatment. FL-mobilized FCs, most of which express a preDC phenotype, significantly enhance engraftment of HSCs and induce donor-specific tolerance to skin allografts. However, p-preDCs alone or p-preDCs from the FC population facilitate HSC engraftment less efficiently than total FCs. Moreover, FCs depleted of preDCs completely fail to facilitate HSC engraftment. These results are the first to define a direct functional role for p-preDCs in HSC engraftment, and also suggest that p-preDCs need to be in a certain state of maturation/activation to be fully functional.

Abbreviations used: CM, chimera media; CSM, cell sort media; FC, facilitating cell; FL, Flt3 ligand; GVHD, graft-versus-host disease; HSC, hematopoietic stem cell; MST, median survival time; p-preDC, plasmacytoid precursor DC; TBI, total body irradiation; TCD, T cell depletion; TLR, toll-like receptor.

I.J. Fugier-Vivier and F. Rezzoug contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS